Manufacturer
Celltrion
Pharmaceutical manufacturer based in South Korea
South Korea
- Products listed
- 20
- Molecules
- 7
- Therapy areas
- 4
Celltrion is a pharmaceutical manufacturer based in South Korea. MedsAcross lists 20 of its products across 7 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- South Korea
- Indian manufacturer
- No
- Also listed as
- CELLTRION USA Inc., CELLTRION USA, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Celltrion products through licensed channels, with the documents your regulator needs.
Immunology and transplant
11 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Adalimumab kit Cold chainGeneric name | Adalimumab | US FDA | Available on request |
| Avtozma 162 mg/0.9 mL injectionSubcutaneous Cold chain | Tocilizumab | US FDA | Available on request |
| Avtozma 200 mg/10 mL injectionIntravenous Cold chain | Tocilizumab | US FDA | Available on request |
| Avtozma 400 mg/20 mL injectionIntravenous Cold chain | Tocilizumab | US FDA | Available on request |
| Avtozma 80 mg/4 mL injectionIntravenous Cold chain | Tocilizumab | US FDA | Available on request |
| Steqeyma 130 mg/26 mL injectionIntravenous Cold chain | Ustekinumab | US FDA | Available on request |
| Steqeyma 45 mg/0.5 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
| Steqeyma 90 mg/1 mL injectionSubcutaneous Cold chain | Ustekinumab | US FDA | Available on request |
| Yuflyma kit Cold chain | Adalimumab | US FDA | Available on request |
| Zymfentra kit Cold chain | Infliximab | US FDA | Available on request |
| Zymfentra 120 mg/mL injectionSubcutaneous Cold chain | Infliximab | US FDA | Available on request |
Bone health
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Denosumab 120 mg/1.7 mL injectionSubcutaneous Cold chainGeneric name | Denosumab | US FDA | Available on request |
| Denosumab 60 mg/1 mL injectionSubcutaneous Cold chainGeneric name | Denosumab | US FDA | Available on request |
| Osenvelt 120 mg/1.7 mL injectionSubcutaneous Cold chain | Denosumab | US FDA | Available on request |
| Stoboclo 60 mg/1 mL injectionSubcutaneous Cold chain | Denosumab | US FDA | Available on request |
Respiratory
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Omlyclo 150 mg/1 mL injectionSubcutaneous Cold chain | Omalizumab | US FDA | Available on request |
| Omlyclo 300 mg/2 mL injectionSubcutaneous Cold chain | Omalizumab | US FDA | Available on request |
| Omlyclo 75 mg/0.5 mL injectionSubcutaneous Cold chain | Omalizumab | US FDA | Available on request |
Oncology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vegzelma 100 mg/4 mL injectionIntravenous Cold chain | Bevacizumab | US FDA | Available on request |
| Vegzelma 400 mg/16 mL injectionIntravenous Cold chain | Bevacizumab | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Celltrion
Send a request for any of these products. We confirm the licensed source, documents and lead time.